Annex Publishers

Australian scientists have recently uncovered a groundbreaking discovery suggesting that diabetes, specifically type 1 diabetes, may be effectively treated using existing cancer drugs. The research indicates that two types of drugs commonly employed in cancer treatments have demonstrated the potential to prevent type 1 diabetes, with the remarkable capability of inducing insulin hormone production within the pancreas in as little as 48 hours. The experimental validation of this approach involved a successful trial conducted on three individuals, providing encouraging results that could revolutionize diabetes treatment. With more than 420 million people worldwide grappling with diabetes, this discovery holds significant promise for addressing a global health challenge. Further research and clinical trials are warranted to explore the full potential and safety of these cancer drugs as a potential cure for diabetes. If successful, this innovative approach may offer new hope to millions living with diabetes and pave the way for transformative advancements in diabetes care

Background: Urinary tract infection is one of the most common bacterial infections encountered by clinicians in developing countries. A biofilm is a structured consortium of bacteria embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA. Antibiotic resistance is a problem of deep scientific concern both in hospital and community settings. This study was aimed to determine the biofilm producers among multidrug uropathogenic bacteria isolated from urine cultures

Maintenance hemodialysis (MHD) is the most effective interventional therapy for patients with chronic kidney disease (CKD). Our aim was to investigate the serum levels of aluminum (Al) and arsenic (As) in CKD patients. Methods: A total of 29 CKD patients receiving MHD were surveyed for selected biochemical, and dialysis quality indices. Serum Al and As levels were measured before and after MHD. Statistical analyses included independent samples t-test or Mann-Whitney, Kaplan-Meier, Pearson, or Spearman's rho correlations

Wilt disease of tomato is caused by Fusarium oxysporum f. sp. lycopersici and it is an important disease which causes significant yield reduction in the crop throughout the world. A study was undertaken to isolate, identify and test the pathogenicity of F. oxysporum f. sp. Lycopersici on tomato; and to evaluate the bioactivity of Azadirachta indica leaf, Piper guineense seed and Zingiber officinale rhizome extracts as well as the synthetic fungicide, mancozeb at different concentrations and combinations for the management of F. oxysporum f. sp. lycopersici in vitro. Results revealed that the percentage frequency of the fungus isolated and identified was more on the roots (35.56 %) than the stems (26.67 %), fruits (20.00 %) and leaves (17.77 %). Results of the pathogenicity test showed more virulence in the roots than in other parts of the tomato plant. Extracts of the three plants and mancozeb proved effective in controlling the mycelial growth of the fungus either alone or when combined. Mancozeb consistently gave 100 % growth inhibition irrespective of the concentration used. Among the plant extracts applied alone at 40 g/L, Z. officinale (66.69 %) was the most effective followed by P. guineense (53.52 %) while A. indica was the least (36.99 %). The mycelial growth inhibition increased from 40 g/L to 120 g/L irrespective of the combination of the treatments used. A combination of mancozeb with any plant extract was more effective than a combination of the plant extracts. It is therefore, recommended that the plant extracts be applied either alone or in combination with other plant extracts or the fungicide to control F. oxysporum f. sp. lycopersici, increase tomato yield and reduce postharvest rots associated with the pathogen